<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Iwamoto M</submitter><funding>JST Core Research for Evolutional Science and Technology</funding><funding>Smoking Research Foundation</funding><funding>Takeda Science Foundation</funding><funding>Japan Agency for Medical Research and Development</funding><funding>Mochida Memorial Foundation for Medical and Pharmaceutical Research</funding><funding>Kyushu University Qdai-jump Research Program</funding><funding>Japan Science and Technology Agency</funding><funding>Yasuda Memorial Medical Foundation</funding><funding>Japan Society for the Promotion of Science</funding><pagination>800-807</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6970923</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>295(3)</volume><pubmed_abstract>Sodium taurocholate cotransporting polypeptide (NTCP) is expressed at the surface of human hepatocytes and functions as an entry receptor of hepatitis B virus (HBV). Recently, we have reported that epidermal growth factor receptor (EGFR) is involved in NTCP-mediated viral internalization during the cell entry process. Here, we analyzed which function of EGFR is essential for mediating HBV internalization. In contrast to the reported crucial function of EGFR-downstream signaling for the entry of hepatitis C virus (HCV), blockade of EGFR-downstream signaling proteins, including mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K), and signal transducer and activator of transcription (STAT), had no or only minor effects on HBV infection. Instead, deficiency of EGFR endocy</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network.</pubmed_title><pmcid>PMC6970923</pmcid><funding_grant_id>JP19fk0310114j0003</funding_grant_id><funding_grant_id>MIRAI</funding_grant_id><funding_grant_id>JP19J21455</funding_grant_id><funding_grant_id>JP19fk0310103j0203</funding_grant_id><funding_grant_id>JP19fk0210036j0002</funding_grant_id><funding_grant_id>JP19fm0208019j0003</funding_grant_id><funding_grant_id>JP19fk0310101j1003</funding_grant_id><funding_grant_id>JP17H04085</funding_grant_id><funding_grant_id>JP19K16672</funding_grant_id><pubmed_authors>Suzuki R</pubmed_authors><pubmed_authors>Iwamoto M</pubmed_authors><pubmed_authors>Iwami S</pubmed_authors><pubmed_authors>Ohashi H</pubmed_authors><pubmed_authors>Matano T</pubmed_authors><pubmed_authors>Aizaki H</pubmed_authors><pubmed_authors>Nishioka K</pubmed_authors><pubmed_authors>Park SY</pubmed_authors><pubmed_authors>Sureau C</pubmed_authors><pubmed_authors>Saso W</pubmed_authors><pubmed_authors>Yun JH</pubmed_authors><pubmed_authors>Sugiyama R</pubmed_authors><pubmed_authors>Muramatsu M</pubmed_authors><pubmed_authors>Ohshima T</pubmed_authors><pubmed_authors>Ryo A</pubmed_authors><pubmed_authors>Watashi K</pubmed_authors><pubmed_authors>Ohki M</pubmed_authors><pubmed_authors>Wakita T</pubmed_authors></additional><is_claimable>false</is_claimable><name>The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal network.</name><description>Sodium taurocholate cotransporting polypeptide (NTCP) is expressed at the surface of human hepatocytes and functions as an entry receptor of hepatitis B virus (HBV). Recently, we have reported that epidermal growth factor receptor (EGFR) is involved in NTCP-mediated viral internalization during the cell entry process. Here, we analyzed which function of EGFR is essential for mediating HBV internalization. In contrast to the reported crucial function of EGFR-downstream signaling for the entry of hepatitis C virus (HCV), blockade of EGFR-downstream signaling proteins, including mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K), and signal transducer and activator of transcription (STAT), had no or only minor effects on HBV infection. Instead, deficiency of EGFR endocy</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2025-04-26T18:55:41.985Z</modification><creation>2021-02-20T22:08:53Z</creation></dates><accession>S-EPMC6970923</accession><cross_references><pubmed>31836663</pubmed><doi>10.1074/jbc.AC119.010366</doi><doi>10.1074/jbc.ac119.010366</doi></cross_references></HashMap>